| Richard Eugene Torkelson, MD | |
|
2301 House Ave, Suite 505, Cheyenne, WY 82001-3179 | |
| (307) 632-9261 | |
| (307) 634-9170 |
| Full Name | Richard Eugene Torkelson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 53 Years |
| Location | 2301 House Ave, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477548881 | NPI | - | NPPES |
| 82001A002 | Other | WY | TRICARE |
| 0726680001 | Other | DMERC | |
| 301231 | Other | WY | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2601A (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheyenne Orthopaedics Pc | 0941113229 | 3 |
News Archive
A new study aims to determine the underlying etiology of seizures and help to target therapy, improve control of seizures, and potentially reduce morbidities in children.
Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
In today's headlines, Medicare tries bundled payments and HHS signals that it may give states a second chance to avoid a federally-run health insurance exchange.
A new cohort study could facilitate targeted interventions for adolescent offenders who are at a high risk of hepatitis C (HCV) infection and obesity related liver disease.
› Verified 1 days ago
| Entity Name | Cheyenne Orthopaedics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386639797 PECOS PAC ID: 0941113229 Enrollment ID: O20031112000167 |
News Archive
A new study aims to determine the underlying etiology of seizures and help to target therapy, improve control of seizures, and potentially reduce morbidities in children.
Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
In today's headlines, Medicare tries bundled payments and HHS signals that it may give states a second chance to avoid a federally-run health insurance exchange.
A new cohort study could facilitate targeted interventions for adolescent offenders who are at a high risk of hepatitis C (HCV) infection and obesity related liver disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Eugene Torkelson, MD 2301 House Ave, Suite 505, Cheyenne, WY 82001-3179 Ph: (307) 632-9261 | Richard Eugene Torkelson, MD 2301 House Ave, Suite 505, Cheyenne, WY 82001-3179 Ph: (307) 632-9261 |
News Archive
A new study aims to determine the underlying etiology of seizures and help to target therapy, improve control of seizures, and potentially reduce morbidities in children.
Amorfix Life Sciences and Aragen Bioscience, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Using its proprietary ProMIS(TM) computational platform discovery technology, Amorfix has identified several disease specific epitopes ("DSEs") on misfolded Fas receptor. Aragen will use those DSEs to generate highly specific monoclonal antibodies ("mAbs").
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
In today's headlines, Medicare tries bundled payments and HHS signals that it may give states a second chance to avoid a federally-run health insurance exchange.
A new cohort study could facilitate targeted interventions for adolescent offenders who are at a high risk of hepatitis C (HCV) infection and obesity related liver disease.
› Verified 1 days ago
Jean Denise Basta, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2301 House Ave, Suite 505, Cheyenne, WY 82001 Phone: 307-632-9261 Fax: 307-634-9170 | |
John E Winter Ii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4017 Rawlins St, Cheyenne, WY 82001 Phone: 307-635-4300 Fax: 307-635-4309 | |
W. Carlton Reckling, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 E 20th St, Suite 300, Cheyenne, WY 82001 Phone: 307-632-6637 Fax: 307-632-3382 | |
Dr. Bret Ryan Winter, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4017 Rawlins St, Cheyenne, WY 82001 Phone: 307-635-4300 Fax: 307-635-4309 | |
Michael Pete Kuhn, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5307 Yellowstone Rd, Cheyenne, WY 82009 Phone: 307-778-0922 | |
Bruce D Smith, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4017 Rawlins St, Cheyenne, WY 82001 Phone: 307-635-2562 Fax: 307-432-2676 |